Cisplatin resistance in ovarian cancer: exploration and insights from metal ion homeostasis imbalance
Chong Chen, Yaqing Li, Yu Zhang, Sailong Liu, Yang Li, Luyan Shen · 2026
Read Cisplatin resistance in ovarian cancer: exploration and insights from metal ion homeostasis imbalance by Chong Chen, Yaqing Li, Yu Zhang, Sailong Liu, Yang Li, Luyan Shen (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13287926.txt.
Description
Chong Chen and colleagues review cisplatin resistance in ovarian cancer through the lens of metal balance, in a 2026 article. Cisplatin is a platinum drug that anchors ovarian cancer treatment, yet tumors often learn to resist it. The review focuses on how cancer cells handle copper and iron inside their mitochondria, the cell's energy hubs. Both metals drive chemical stress reactions that can either protect the cell or kill it.
Too much copper can trigger a death pathway called cuproptosis, in which key energy proteins clump together. Disturbed iron handling drives a different death route, ferroptosis, through damage to cell fats. The authors connect these pathways with the metabolic rewiring that resistant tumors undergo. They argue that pushing metal balance off center could restore sensitivity to platinum drugs. The piece maps research leads rather than reporting a new trial.
Catalog record
| CREATOR | Chong Chen, Yaqing Li, Yu Zhang, Sailong Liu, Yang Li, Luyan Shen |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 83 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |